Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioXcel Therapeutics Inc.

    NASDAQ: BTAI · Real-Time Price · USD
    5.06
    0.31 (6.53%)
    At close: Aug 15, 2025, 1:18 PM

    BioXcel Therapeutics Revenue

    BioXcel Therapeutics reported an annual revenue of $2.27M, reflecting a 64.2% growth. For the quarter ending June 30, 2025, BioXcel Therapeutics generated $120K in revenue.
    Revenue (ttm)
    2.27M
    Revenue Growth
    64.2%
    Price / Sales Ratio
    6.69
    Revenue / Employee
    61.24K
    Employees
    37
    Market Cap
    30.64M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist